Immunoglobulin D (IgD) is an enigmatic antibody isotype that mature B cells express together with IgM through alternative RNA splicing. Here we report active T cell-dependent and T cell-independent IgM-to-IgD class switching in B cells of the human upper respiratory mucosa. This process required activation-induced cytidine deaminase (AID) and generated local and circulating IgD-producing plasmablasts reactive to respiratory bacteria. Circulating IgD bound to basophils through a calcium-mobilizing receptor that induced antimicrobial, opsonizing, inflammatory and B cell-stimulating factors, including cathelicidin, interleukin 1 (IL-1), IL-4 and B cell-activating factor (BAFF), after IgD crosslinking. By showing dysregulation of IgD class-switched B cells and 'IgD-armed' basophils in autoinflammatory syndromes with periodic fever, our data indicate that IgD orchestrates an ancestral surveillance system at the interface between immunity and inflammation.
Immunoglobulin D (IgD) has remained an enigmatic antibody class since its discovery more than 40 years ago 1 . Because of its spotty presence in mammals and absence in birds, IgD was initially thought to be a recently evolved immunoglobulin isotype 2 . By showing that xenopous IgD is orthologous to IgW, an antibody class found in cartilaginous fish and lungfish, published studies have demonstrated that IgD was present in the ancestor of all jawed vertebrates and arose together with IgM at the time of the emergence of the adaptive immune system, approximately 500 million years ago 3 . Although IgM remains stable over evolutionary time, IgD shows greater structural plasticity and can be expressed mainly as a transmembrane or secretory molecule in a species-specific way 4, 5 . One possible interpretation is that the gene encoding IgD has been preserved as a structurally flexible locus to complement the functions of IgM.
IgM and IgD are the first antibody isotypes expressed during B cell ontogeny. Bone marrow B cell precursors acquire surface IgM after assembling heavy-chain (H) and light-chain (L) variable-region exons from prototypic variable (V), diversity (D) and joining (J) gene segments through an antigen-independent process mediated by the RAG-1 and RAG-2 recombinases 6 . After leaving the bone marrow to colonize secondary lymphoid organs, B cells acquire surface IgD of the same specificity as surface IgM through alternative splicing of a pre-mRNA composed of V(D)J and both heavy-chain constant exons (C m and C d ) 7 . The importance of dual expression of IgM and IgD remains unclear, because either isotype largely compensates for the loss of the other [8] [9] [10] .
After encountering antigen in secondary lymphoid organs, mature B cells transcriptionally downregulate surface IgD 11 and thereafter undergo somatic hypermutation and class-switch recombination (CSR) of DNA, two immunoglobulin gene-diversifying processes that require the DNA-editing enzyme AID (activation-induced cytidine deaminase) 12 . Somatic hypermutation introduces point mutations into V H DJ H and V L J L exons, thereby providing the structural correlate for the selection of high-affinity immunoglobulin variants by antigen 13 , whereas CSR substitutes the C m gene with C g , C a or C e , thereby generating secondary IgG, IgA and IgE isotypes with the same antigen-binding specificity as IgM but additional effector functions 14 . Of note, CSR occurs through either a T cell-dependent follicular pathway involving engagement of the receptor CD40 on B cells by CD40 ligand (CD40L) on antigen-activated CD4 + T cells or a T cellindependent extrafollicular pathway involving engagement of the receptors TACI and BAFF-R on B cells by BAFF and APRIL, two CD40L-related members of the tumor necrosis factor (TNF) family that are released by antigen-activated dendritic cells, macrophages and mucosal epithelial cells [15] [16] [17] [18] [19] [20] [21] . Ultimately, antigen-experienced B cells generate antibody-secreting plasma cells and memory B cells 22 . The latter cells form new plasma cells after exposure to previously encountered antigens. In general, plasma cell-derived IgG, IgA and IgE antibodies facilitate the elimination of invading pathogens by activating powerful Fc receptors that enhance the phagocytic, cytotoxic and proinflammatory functions of various innate immune cells, including granulocytes 23 .
Instead of switching from IgM to IgG, IgA or IgE, some B cells switch to IgD 24 , which suggests that IgD confers some functional advantage over IgM. The resulting IgD + IgM À plasma cells release highly substituted mono-and polyreactive IgD antibodies containing mostly l-light chains into the blood as well as into respiratory, salivary, lacrimal and mammary secretions 1, 4, [25] [26] [27] [28] . Secreted IgD might enhance immune protection by regulating B cell homeostasis and activation. Indeed, IgD-deficient mice have fewer B cells, delayed affinity maturation and less production of IgG1 and IgE, two isotypes highly dependent on the cytokine interleukin 4 (IL-4; A001262) 8, 9 . Conversely, mice injected with a goat polyclonal antibody to mouse IgD (antimouse IgD) with potential agonistic activity produce more IgG1 and IgE and show robust IL-4 production by T cells and basophils [29] [30] [31] . The latter cells are a small granulocytic subset that triggers T cell and B cell responses by releasing IL-4 after recognizing antigen through prebound IgE and IgG [32] [33] [34] [35] . Whether IgD also facilitates antigen recognition by basophils remains unknown.
We found that B cells of the human upper respiratory mucosa generated local and circulating IgD + IgM À plasmablasts by undergoing C m -to-C d CSR through both T cell-dependent follicular and T cellindependent extrafollicular pathways involving AID. Circulating IgD interacted with basophils through a calcium-fluxing receptor that induced antimicrobial, opsonizing, inflammatory and immunostimulating factors such as cathelicidin, pentraxin-3 (PTX3), IL-1, IL-4 and B cell-activating factor of the TNF family member (BAFF; A000383). Finally, IgD class-switched B cells and 'IgD-armed' basophils were dysregulated in patients with hyper-IgD and autoinflammatory syndromes, which indicates that IgD coordinates a surveillance system at the crossroads of immunity and inflammation. This system may not only monitor invasion by respiratory bacteria but also regulate antibody responses.
RESULTS

IgD production occurs in the upper respiratory mucosa
Human B cells release IgD into the blood as well as into respiratory, salivary, lacrimal and mammary secretions 1, 4, 25, 27 . We used immunohistochemistry, light microscopy and flow cytometry to elucidate the 'geography' and phenotype of IgD + IgM À B cells. Unlike intestinal, hepatic, lymph node, splenic and hematopoietic tissues, tonsillar and nasal tissues contained abundant IgD + IgM À B cells with topographic and morphologic features distinct from those of conventional IgD + IgM + B cells (Fig. 1a,b) . The latter occupied the follicular mantle but not the germinal center of secondary lymphoid follicles, had a small size, round shape, scant cytoplasm and large nuclei, and expressed either k-or l-light chains on their surface in addition to the 'pan-B cell' molecules CD19, CD20, CD21, CD22, CD24, CD39, CD40, major histocompatibility complex (MHC) class I and class II, BAFF-R, transmembrane activator and CAML interactor (TACI), and the transcription factor Pax5 ( Fig. 1c and Supplementary Fig. 1 ).
In contrast, IgD + IgM À B cells populated both germinal center and extrafollicular areas, had an ovaloid-elongated shape, medium-large size, abundant cytoplasm containing C d IgH chains 'preferentially' coupled with l-light chains, and small and often picnotic eccentric nuclei. Consistent with published data 24, 26, 27 , these IgD + IgM À plasmablasts accounted for up to 20-25% of antibody-forming plasma cells and about 1.5-5% of total CD19 + B cells in tonsils. Despite their plasma cell morphology, only a subset of IgD + IgM À B cells expressed Blimp-1 and BCMA, and almost none of them expressed CD138 (syndecan-1), three hallmarks of mature plasma cells 36 . Furthermore, IgD + IgM À plasmablasts retained surface immunoglobulin as well as CD19, CD20, CD21, CD22, CD24, CD39, CD40, MHC class I and class II, BAFF-R, TACI and Pax5, which are usually downregulated by terminally differentiated plasma cells 36 .
In addition to showing a bias for surface l-light chains, some or all IgD + IgM -plasmablasts expressed CD5, an activation-induced B cell molecule 37 ; CD10, CD38, CD77 and Ki67, hallmarks of germinal center B cells 24 ; CD27, a key effector-memory B cell molecule 38 ; and AID, a DNA-editing enzyme associated with ongoing class switching 18, 19 . We found similar IgD + IgM À blasts in the peripheral blood ( Supplementary Fig. 1 ), where they accounted for 0.5-1% of circulating CD19 + B cells. Our data indicate that the upper respiratory mucosa generates local and circulating IgD + IgM À plasmablasts specialized in IgD production. These cells have a complex phenotype that probably reflects a derivation from multiple follicular and extrafollicular precursors, including germinal center B cells.
Upper respiratory mucosa B cells undergo IgD CSR in situ B cells express C H genes downstream of C m through a CSR reaction that relies on switch (S) regions 14 . Positioned upstream of each C H gene and an intronic (I) exon, S regions undergo germline transcription after exposure of B cells to the appropriate stimuli 14 . In addition to yielding I H -C H transcripts, germline transcription renders S regions substrates for DNA modifications by the CSR machinery, including AID 14 . Processing of these modifications into double-stranded DNA breaks is followed by fusion of these breaks through the nonhomologous end-joining pathway and looping-out deletion of the intervening DNA 14 . Ultimately, CSR generates post-switch I m -C H transcripts as well as an extrachromosomal S-S switch circle (Fig. 1d) . Together with AID, switch circles are generally accepted as a marker of ongoing class switching, because they have a short half-life due to their rapid degradation by cellular nucleases 12, 14, 18, 19 . In addition, switch circles do not replicate with the class-switched B cell and therefore become rapidly diluted after CSR takes place.
Similar to cows 39 marrow, lymph nodes or intestine (Fig. 1e) . CSR from C m to C d was associated with active transcription of C d genes, because both the pre-germinal center IgD + IgM + B cell line 2E2 and tonsillar follicular mantle IgD + IgM + B cells contained chimeric germline I m -C d transcripts in addition to conventional germline I m -C m transcripts (Fig. 1f,g ). Fig. 2 and data not shown). Of note, we confirmed the specificity of in vitro-induced s d -S m switch circles by sequencing (data not shown).
We further studied the IgD-inducing function of CD40L, BAFF and APRIL in patients with primary immunodeficiencies. Defects in the genes encoding CD40L (CD40LG; called 'TNFSF5' here) and CD40 (CD40; called 'TNFRSF5' here), which impair CD40L and CD40 signaling in patients with hyper-IgM type 1 (HIGM1) syndrome and HIGM3 syndrome 43 , respectively, led to fewer circulating and follicular IgD + IgM À plasmablasts but partially spared extrafollicular IgD + IgM À plasmablasts ( Fig. 2d and Supplementary Fig. 3 ), which suggests that the CD40L-CD40 interaction is indispensable for the generation of systemic but not mucosal IgD-producing effectormemory B cells. Defects in TNFRSF13B, which impair TACI signaling in a subset of patients with common variable immunodeficiency (CVID) 44, 45 , were also associated with fewer circulating IgD + IgM À plasmablasts. Defects in AICDA, which impair AID function in patients with HIGM2 syndrome 43 , resulted in fewer circulating and follicular IgD + IgM À plasmablasts. This was linked to a lack of functional AID protein, because B cells from HIGM2 patients neither induced s d -S m switch circles nor underwent loss of surface IgD after exposure to appropriate stimuli ( Fig. 2e and Supplementary Fig. 3 ). Of note, HIGM2 syndrome as well as HIGM3 syndrome were associated with greater generation of 'double-producing' IgD + IgM + plasmablasts at both follicular and extrafollicular mucosal sites, possibly reflecting the activation of a CSR-independent pathway for compensatory IgD synthesis. Thus, IgD CSR requires AID and occurs through both T cell-dependent and T cell-independent pathways in vivo.
IgD recognizes respiratory bacteria
Given their origin in the upper respiratory mucosa, IgD + IgM À plasmablasts may release IgD antibodies that recognize airborne bacteria. Consistent with this possibility, IgD secreted by stimulated IgD + IgM À plasmablasts bound to the Gram-negative bacteria Moraxella catarrhalis and Haemophilus influenzae type a and type b (Fig. 2f) . As shown before 46 , IgD also bound the virulence factor M. catarrhalis IgD-binding protein (MID; also known as Hag), which facilitates the adhesion of M. catarrhalis to mucosal epithelial cells. Furthermore, secreted IgD reacted to lipopolysaccharide (LPS), a key parietal component of Gram-negative bacteria, and capsular polysaccharide (CPS), an essential protective factor for encapsulated bacteria such as H. influenzae. Thus, IgD from IgD + IgM À B cells recognizes respiratory bacteria and their products.
IgD binds to circulating basophils
Humans have 15-300 mg/ml of circulating IgD 1, 27 , which probably originates from IgD + IgM À plasmablasts that enter the bloodstream from inductive sites in the upper respiratory mucosa. To elucidate the function of circulating IgD, we examined its in vivo interaction with Fc receptor-blocked peripheral blood leukocytes by flow cytometry. Using a goat polyclonal antibody highly specific for human IgD and with no Fc portion and no IgG cross-reactivity, we found that basophils had abundant surface IgD, whereas T cells, natural killer cells, monocytes, myeloid dendritic cells, neutrophils, eosinophils and plasmacytoid dendritic cells showed no or little surface IgD ( Fig. 3a and Supplementary Fig. 4 ). Basophils were also consistently positive for surface IgD binding when stained with a monoclonal anti-IgD ( Supplementary Fig. 4) .
Compared with polyclonal anti-IgD, monoclonal anti-IgD detected less IgD on circulating basophils. In addition, monoclonal anti-IgD tended to detect less IgD on circulating neutrophils, although there was interperson variability. These results probably reflected the wide range of serum IgD concentrations present in different people as well as the fact that monoclonal antiIgD reagents allow a less complete detection of IgD because of their ability to detect only individual monomorphic C d epitopes and not multiple C d epitopes and conformations, as the polyclonal anti-IgD does 47 . In this context, transmembrane and secreted IgD 'preferentially' associate with k-and l-light chains, respectively 4 . This phenomenon, known as the 'IgD paradox', probably generates conformational differences in C d that further limit the recognition of secreted IgD by monoclonal antibodies to IgD. Of note, one of the monoclonal anti-IgD reagents used in this study failed to effectively stain both soluble IgD bound on KU812 cells and transmembrane IgD on B cells (data not shown), which suggests poor fluorochrome conjugation and/or intrinsically weak reactivity to C d .
We detected IgD not only on the surface but also in the cytoplasm of circulating as well as mucosal basophils (Fig. 3b) , which suggests that basophils internalize IgD-bound immune complexes. Mast cells, which are mucosal immunocytes functionally related to basophils 48, 49 , were also positive for IgD ( Supplementary Fig. 5 ). The addition of exogenous monoclonal IgD did not increase the surface IgD binding on basophils (Fig. 3c) , which indicated saturation of binding sites by endogenous IgD. However, monoclonal IgD did bind to basophils after they were stripped of endogenous IgD. Finally, the addition of increasing amounts of unlabeled monoclonal IgD progressively diminished the binding of labeled monoclonal IgD to basophils stripped of endogenous IgD (Fig. 3d) . C o n t r o l H e a t d e n a t u r a t io n lg G lg A lg E M a n n o s e M a n n a n T r y p s in P e p s in P a p a in P a p a in We confirmed the specific tropism of IgD for basophils and mast cells in vitro by showing binding of physiological concentrations (from 0.5 mg/ml to 50 mg/ml) of polyclonal or monoclonal IgD molecules to the pre-basophilic cell line KU812 and to the mastocytoid cell lines HMC-1 and LAD-2 ( Fig. 4a and Supplementary  Fig. 6 ). This binding was highly specific, as it was detected with both polyclonal and monoclonal anti-IgD reagents with no crossreactivity for IgG. Except for the monocytic cell line U937, none of the T cell, NK cell or myeloid cell lines tested bound IgD. KU812 and LAD-2 cells upregulated IgD binding after exposure to IL-3 and/or IL-4 ( Fig. 4b and Supplementary Fig. 7) , two cytokines involved in basophil and mast cell differentiation 48, 49 . In addition to augmenting their IgD-binding activity, IL-3 stimulated KU812 cells to increase surface expression of CD124 (IL-4 receptor) and FceRI (IgE receptor) and decrease expression of CD117 (c-Kit), whereas IL-4-stimulated LAD-2 cells increased expression of CD123 (IL-3 receptor). Binding of labeled IgD to KU812 or HMC-1 cells was saturable and was diminished by competition with unlabeled IgD but not IgG or IgE, whereas IgA had a minimal inhibitory effect (Fig. 4c,d ).
As both IgA and IgD are highly mannosylated 50 , IgD could use mannose to enhance its binding to basophils and mast cells. In agreement with that, mannose and mannan slightly inhibited the binding of IgD to target cells (Fig. 4d) . Finally, IgD binding was abolished by denaturation of IgD or by pretreatment of target cells with trypsin and papain but not by pretreatment with pepsin. Thus, IgD binds to basophils and mast cells through a protease-sensitive, IL-3-or IL-4-inducible receptor distinct from receptors for IgG, IgA and IgE.
Binding of IgD to basophils is evolutionarily conserved
IgD is an ancestral antibody class expressed by early vertebrates, including teleost fish [3] [4] [5] . Because channel catfish (Ictalurus punctatus) express both transmembrane and secreted IgD molecules 5 , it was relevant that the peripheral blood of some of these animals contained plasmablast-like IgD + IgM À B cells expressing transcripts for both transmembrane and secreted C d IgH chains but not for transmembrane and secreted C m IgH chains ( Supplementary Fig. 8 ). Flow cytometry with specific monoclonal antibodies showed that catfish also have circulating granular leukocytes armed with surface IgD but not IgM. These IgD + IgM À granulocytes contained neither transcripts 
IgD-activated basophils produce B cell-activating factors
To elucidate its functions, we crosslinked IgD on basophils with a specific monoclonal anti-IgD in the presence or absence of the basophil maturation factor IL-3 (refs. 48, 49) . Controls were an isotype-matched irrelevant antibody or anti-IgE. IgE binds basophils through a high-affinity receptor, FceRI, that triggers degranulation and histamine release after crosslinking 48, 49 . Unlike IgE crosslinking, IgD crosslinking elicited neither surface upregulation of the granular molecule CD63 nor histamine release regardless of the presence of IL-3 (Fig. 5a,b and Supplementary Fig. 9 ). Although it was less efficient than IgE crosslinking in inducing membrane-bound CD40L and BAFF, IgD crosslinking was more efficient than or as efficient as IgE crosslinking in inducing soluble IL-4, IL-13 and BAFF, membranebound APRIL, and soluble IL-8 and CXCL10 (Fig. 5c and Supplementary Fig. 9 ), two chemokines active on monocytes, neutrophils and T cells. These effects were potentiated by IL-3. Activated basophils usually release mediators by undergoing calcium-dependent degranulation after crosslinking of IgE by antigen 48, 49 . Although it was unable to induce degranulation, IgD crosslinking triggered intracellular calcium fluxes that were more sustained than those induced by IgE (Fig. 5d) . The basophil-stimulating activity of IgD was further confirmed by experiments showing that in the presence of IgD crosslinking, basophils given no pretreatment or pretreated with IL-3 acquired the ability to induce IgM secretion as well as IgG and IgA class switching in B cells (Fig. 5e) . Of note, the 'B cell-licensing' function of basophils with crosslinked IgD was largely dependent on BAFF and APRIL, as it was abolished by a soluble TACIimmunoglobulin decoy receptor (data not shown). As shown before 32 , basophils with crosslinked IgE elicited B cell activation mostly through CD40L (data not shown). Thus, IgD stimulates basophils through a calcium-fluxing receptor that induces many cytokines, including the B cell-activating factors IL-4, IL-13, BAFF and APRIL.
IgD-stimulated basophils produce antimicrobial factors
In addition to triggering adaptive B cell responses, IgD-activated basophils may trigger innate antimicrobial responses 48, 49 . Indeed, basophils with crosslinked IgD induced antimicrobial, opsonizing and alarm-signaling factors [51] [52] [53] , including transcripts for b-defensin 3, cathelicidin, the A and F isoforms of SPAG11, the D and G isoforms of SPAG11, PTX3 and CRP (Fig. 6a) . In addition, IgD-stimulated basophils released the cathelicidin-derived peptide LL-37 (Fig. 6b) . Consistent with those results, supernatants from basophils with crosslinked IgD inhibited the replication of M. catarrhalis and H. influenzae (Fig. 6c) . In contrast, basophils with crosslinked IgE had little or no antimicrobial activity. Thus, IgD crosslinking activates powerful antimicrobial, opsonizing and alarm-signaling programs in basophils.
Dysregulated basophils in patients with hyper-IgD syndrome
To elucidate the relationship between IgD and basophils in vivo, we analyzed IgD class-switched B cells and 'IgD-armed' basophils from patients with hyper-IgD syndrome (HIDS), TNF receptor-associated periodic fever syndrome (TRAPS), Muckle-Wells syndrome (MWS) and periodic fever-aphthous stomatitis-pharyngitis-cervical adenitis (PFAPA) syndrome. Although characterized by diverse genetic defects, these autoinflammatory disorders share a perturbation of the mechanisms that initiate and control the inflammatory reaction. Such perturbation causes periodic attacks of fever and tissue damage as well as abnormal release of IL-1 and TNF and high IgD production 4, 54 .
Patients with HIDS, TRAPS, MWS and PFAPA syndrome had more circulating and mucosal IgD + IgM À plasmablasts than did healthy subjects ( Fig. 7a and Supplementary Fig. 10 ), which suggests that switching from IgM to IgD is augmented in autoinflammatory syndromes. These disorders were also associated with fewer circulating but more mucosal 'IgD-armed' basophils and probably mast cells (Fig. 7b-d and Supplementary Fig. 10 ), which suggests that high IgD production enhances mucosal homing, proliferation and activation of basophils and mast cells. Consistent with that possibility, mucosal basophils showed signs of hyperactivation, including strong expression of BAFF, APRIL and LL-37.
Knowing that IL-1b and TNF are IgD-inducible proinflammatory cytokines involved in autoinflammatory syndromes 54, 55 , we wondered whether IgD triggering would increase the production of IL-1 and TNF by basophils. After IgD crosslinking, IL-3-treated basophils from healthy subjects released both IL-1b and TNF, and this release was greater in the presence of monocytes (Fig. 7e) , a cell type heavily involved in inflammation. In contrast, IgE crosslinking had little or no IL-1-and TNF-inducing activity. Overall, our data indicate that IgD and basophils orchestrate an ancestral surveillance system at the interface between immunity and inflammation ( Supplementary  Fig. 11 ). Dysregulation of this system may contribute to the pathogenesis of autoinflammatory syndromes with periodic fever.
DISCUSSION
In this study we have reported that human B cells from the upper respiratory mucosa actively switch from S m to s d , thereby generating local and circulating IgD antibodies highly reactive to respiratory bacteria. Circulating IgD bound to basophils through a calciummobilizing receptor that activated antimicrobial, opsonizing, proinflammatory and B cell-stimulating programs after IgD crosslinking. Both IgD class-switched B cells and 'IgD-armed' basophils were dysregulated in patients with autoinflammatory syndromes, periodic fever and high production of IgD, which indicates that IgD class switching mediates not only immunity but also inflammation.
Human B cells release IgD antibodies into the blood as well as into respiratory, salivary, lacrimal and mammary secretions 1, 4, [25] [26] [27] [28] . The regulation and function of these antibodies remain unknown. We found a large fraction of IgD + IgM À plasmablasts in the upper respiratory mucosa. These plasmablasts originated in situ from an active process of S m -to-s d CSR that involved germline I m -C d transcription, required AID expression and occurred through either a T cell-dependent follicular pathway involving engagement of CD40 on B cells by CD40L on T cells or a T cell-independent extrafollicular pathway involving engagement of TACI on B cells by BAFF or APRIL from innate immune cells, possibly including epithelial and dendritic cells [18] [19] [20] .
The composite ontogeny of mucosal IgD + IgM À plasmablasts was consistent with the finding that they had phenotypic traits usually associated with extrafollicular activated B cells or follicular germinal center B cells. Like those B cell types, mucosal IgD + IgM À plasmablasts produce both polyreactive and monoreactive IgD antibodies encoded by nonmutated and mutated V(D)J genes, respectively 28 , which possibly reflects the need of the upper respiratory mucosa to mount maximally diversified IgD responses for frontline defense purposes. Such IgD responses probably entail the stimulation of specific l-chain-positive B cell precursors by a unique 'cocktail' of mucosal signals composed of IL-21 and IL-2 or IL-21 and IL-15, three cytokines released by dendritic cells and T cells 16, 18, 41, 42 . Together with CD40L, BAFF and APRIL, these cytokines might account for the massive V(D)J gene diversification and oligoclonal expansion of IgD + IgM À B cells in tonsils reported before 24, 26 . Why these cells are strongly biased for expression of l-light chain remains unclear. One possibility is that the formation of fully functional soluble IgD antibodies requires pairing of C d IgH with l-light chains.
IgD + IgM À plasmablasts in the peripheral blood are probably in transit from inductive sites in the upper respiratory mucosa to distant mammary, salivary, lacrimal, respiratory, tubal and auditive sites 27, 38, 56 . At these effector sites, soluble IgD antibodies might enhance immune protection against local pathogens and commensal bacteria. Indeed, IgD released by stimulated IgD + IgM À B cells showed 27 , which translocates polymeric IgA and IgM from the basolateral to the apical surface of epithelial cells, monomeric IgD could reach mucosal surfaces through an alternative epithelial transporter, perhaps one similar to the transporter that mediates transcytosis of monomeric IgG 27 . Once on the mucosal surface, IgD could take advantage of its poor complement-inducing activity to mediate immune exclusion in a noninflammatory way 4 . Alternatively, IgD may confine its defensive functions to the subepithelial area of the upper respiratory tract. In addition to mediating mucosal immunity, IgD may enhance systemic immunity by 'educating' circulating innate effector cells as to the antigenic composition of the upper respiratory tract. Indeed, we detected abundant IgD on basophils but not on other leukocytes, except B cells. In the presence of IgD crosslinking, basophils acquired the ability to inhibit the growth of respiratory bacteria, presumably through the induction of b-defensin 3, SPAG11 isoforms, PTX3, CRP and cathelicidins. These antimicrobial and opsonizing factors also have immunostimulating and alarm-inducing activity [51] [52] [53] . Thus, 'IgD-armed' basophils may function as circulating sentinels able to trigger rapid innate and adaptive immune responses after sensing pathogens from the upper respiratory tract.
The primordial nature of this immune surveillance system was confirmed by the presence of both IgD-producing (IgM À ) plasmablasts and 'IgD-armed' granulocytes in channel catfish. The idea that IgD must mediate some important and evolutionarily conserved functions complementary to those of IgM was also suggested by the presence of 'double-producing' IgD + IgM + plasmablasts in patients with HIGM syndromes. This compensatory pathway for IgD production could explain why serum IgD is conserved or even higher in HIGM and other primary immunodeficiencies that result from an overall or selective impairment of CSR, including CVID and selective IgA deficiency 4, 25, 27 .
Consistent with the B cell-activating, antibody-inducing and basophil-stimulating properties of IgD and anti-IgD in vivo 29, 30, 57 , we found that basophils upregulated the production of IL-4, IL-13, BAFF and APRIL after IgD crosslinking in vitro. This effect correlated with the acquisition of 'B cell-licensing' functions, including the ability to elicit IgM secretion as well as IgG and IgA class switching. In addition to promoting T cell-independent humoral immunity, IL-4 and IL-13 from IgD-activated basophils may initiate T cell-dependent humoral immunity by triggering the formation of CD4 + T helper type 2 cells with B cell-helper activity 34, 35 . Thus, it is likely that basophils respond to IgD-reactive pathogens by eliciting not only innate but also adaptive immune responses. Such responses would take place in both systemic and mucosal areas. Indeed, although earlier work showed migration of basophils to draining lymph nodes 34 , we detected basophils in the upper respiratory mucosa, particularly in the presence of inflammation.
Our finding that IgD-stimulated basophils released an obligatory B cell-survival factor such as BAFF would provide a mechanistic explanation for published studies showing that IgD deficiency leads to contraction of the peripheral B cell compartment in mice 8, 58 . As suggested by the poly-and autoreactivity of a large fraction of IgD antibodies 28 , basophils could undergo tonic or intermittent release of BAFF after sensing circulating foreign or autologous antigens through prebound IgD. The ensuing receptor-dependent internalization of antigen-IgD complexes might account for the cytoplasmic accumulation of IgD found in basophils isolated ex vivo.
In addition to binding to basophils, IgD bound to mast cells through an IL-4-inducible calcium-fluxing receptor distinct from the receptors for IgG, IgA and IgE. Indeed, basophil-like and mast cell-like lines pretreated with IgG, IgA and IgE retained IgD-binding activity. A minimal but reproducible inhibition was induced by IgA, the only antibody isotype, together with IgD, that displays C H regionassociated O-linked carbohydrates 50 , which may therefore contribute to the binding of IgD to its receptor sites. The basophilic cell line KU812 increased IgD binding in response to IL-3, a mast cell-derived cytokine that enhances basophil activation and recruitment of basophils to lymphoid and mucosal effector sites 48, 49 . As IL-3 also enhances basophil activation by IgD, basophils and mast cells may form an IgD-mediated IL-3-dependent axis for the amplification of both systemic and mucosal immune responses.
The interaction of IgD with basophils and mast cells was sensitive to the proteolytic activity of trypsin and papain but not to that of pepsin. Published studies have shown that papain initiates IgE responses by inducing the release of IL-4 from basophils through an enzymatic mechanism 34 . One possibility is that IgD and papain interact with similar receptors on basophils. Notably, IgD stimulates basophils through a pathway distinct from that induced by IgE. Indeed, despite eliciting IgE-like intracellular calcium fluxes, IgD crosslinking did not induce degranulation and histamine release. Furthermore, IgD was less effective than IgE crosslinking in upregulating surface CD40L, a powerful class switch-inducing factor 32 . Conversely, IgD was generally more effective than IgE crosslinking in inducing antimicrobial, immunostimulating and proinflammatory factors such as IL-1b, TNF, IL-8 and CXCL10.
The proinflammatory function of IgD was further suggested by the analysis of autoinflammatory syndromes, a group of disorders characterized by periodic attacks of fever and inflammation as well as exaggerated production of IL-1b and IgD 4, 54 . We found more class-switched IgD + IgM À plasmablasts and more mucosal 'IgDarmed' basophils in patients with HIDS, TRAPS, MWS or PFAPA syndrome. In these subjects, mucosal basophils could enhance inflammation by releasing IL-1b and LL-37 in response to microbial antigens with IgD-binding activity. Consistent with that possibility, periodic fever is often triggered by infection or immunization, particularly in patients with HIDS 54 . Similar IgD-binding antigens could also increase basophil expression of B cell-activating and class switch-inducing factors such as CD40L, BAFF and APRIL. This effect could account for the higher serum titers of IgG and IgA often found in people with HIDS, TRAPS, MWS and PFAPA syndrome 4, 54 . Finally, the fact that IgD exerts its activity mainly as a basophil-bound antibody could explain why periodic attacks of fever and inflammation do not predictably correlate with serum IgD in patients with HIDS 54 . In summary, human B cells may produce IgD to 'instruct' basophils as to the antigenic composition of the upper respiratory tract. This evolutionarily conserved immune surveillance system would not only monitor systemic invasion by airborne pathogens but also regulate B cell homeostasis, antibody production and inflammation.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
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ONLINE METHODS
Fresh cells. Peripheral blood mononuclear cells from buffy coats of healthy subjects were from the New York Blood Center. Additional mononuclear cells were isolated from the peripheral blood of patients with primary immunodeficiencies, mastocytosis or autoinflammatory syndromes. Tonsillar and pulmonary mononuclear cells were obtained from tissue specimens of patients undergoing resection of hypertrophic tonsils or lung neoplastic lesions at New York Presbyterian Hospital-Weill Cornell Medical Center. The Institutional Review Board of Weill Medical College of Cornell University approved the use of blood, tonsil and lung specimens for this study, and patients provided informed consent. IgD + IgM + B cells and CD14 + monocytes were sorted magnetically from peripheral blood and tonsillar mononuclear cells as reported 16 . In experiments involving induction of s d -S m switch circles and loss of surface IgM, peripheral blood IgD + IgM + B cell samples were depleted of antigen-experienced plasmablasts with microbeads targeting CD27 (Miltenyi Biotec). For morphological studies, IgD + IgM + and IgD + IgM À B cells were sorted by flow cytometry from tonsillar mononuclear cells. Granulocytes were separated from peripheral blood mononuclear cells with double gradients of Histopaque-1119 and Histopaque-1077 (Sigma). Basophils were purified by negative selection from peripheral blood mononuclear cell samples with a Basophil Isolation kit (Miltenyi Biotec). Mast cells were enriched from lung mononuclear cell samples with a biotin-conjugated monoclonal antibody (mAb) to FceRI (AER-37; eBiosciences) and anti-biotin microbeads (Miltenyi Biotec). Catfish peripheral blood lymphocytes were obtained and stained as reported 5, 59 . Catfish IgM and IgD were detected with mAb 9E1 and mAb 7D11, respectively (available from M. Wilson, Mississippi University Medical Center). Tissues and immunohistochemistry. Frozen and paraffin-embedded tissue sections of tonsils, nasal cavities, intestine, liver, lymph nodes, bone marrow and spleen from healthy subjects or patients with primary immunodeficiencies or autoinflammatory syndromes were stored at À80 1C (frozen sections) or 25 1C, (paraffin-embedded sections). Sections were blocked with a saturating concentration of purified human IgG and were stained for immunohistochemical analysis with various combinations of antibodies (Supplementary Table 1 ) as described 18 . Primary antibodies with irrelevant binding activity and the appropriate secondary reagents were used to test the specificity of tissue staining as described 33 . The proportion of IgD + IgM À plasmablasts in different organs was determined by sequential staining of tissue sections with polyvalent goat polyclonal antibody to human immunoglobulins (H17000; Invitrogen), Alexa Fluor 647-conjugated secondary polyclonal antibody to goat immunoglobulins (A21447; Invitrogen), fluorescein-conjugated goat F(ab¢) 2 polyclonal antibody to human IgD (2032-02; Southern Biotechnology) and biotinconjugated goat F(ab¢) 2 polyclonal antibody to human IgM (AHI1608; Invitrogen). Nuclei were visualized with DAPI (4¢,6-diamidine-2¢-phenylindole dihydrochloride; Boehringer Mannheim). The following formula was used: (number of cytoplasmic IgD + IgM À B cells / number of cytoplasmic immunoglobulin + B cells) Â 100. Sections adjacent to those analyzed for IgM, IgD and total immunoglobulin were stained with mAb to CD123 (7G3; BD Biosciences). IgD + cells with no distinct plasmacytoid morphology but with granular cytoplasm, lobated nucleus and/or CD123 expression were considered basophils and were therefore excluded from analysis. Follicular mantle IgD + IgM À B cells were also excluded from analysis; these B cells have bright IgD expression and dim IgM expression due to the higher stability and less rapid turnover of V(D)J-C d transcripts than of V(D)J-C m transcripts 4 . Pseudocolor images were composed with Metamorph 7.5 (Molecular Devices) and were edited with Photoshop CS2 (Adobe).
Patients. Patients with HIGM syndromes had various mutations of TNFSF5, AICDA or TNFRSF5 that impair the function of CD40L, AID or CD40, respectively 43 . Patients with CVID had a heterozygous mutation of TNFRSF13b that results in the substitution C104R, which prevents the binding of BAFF and APRIL to TACI 44, 45 . The patient with MWS had a heterozygous mutation of NALP3 that results in the substitution C1043T, which enhances the activity of cryopyrin, a key component of the inflammasome 54 . Patients with TRAPS had heterozygous mutations of TNFRSF1A that result in the substitution G173A, G362A or T123G, which prevents cleavage of the extracellular domain of TNF receptor type 1, thereby impairing feedback inhibition of TNF by its soluble decoy receptor 54 . Patients with HIDS had a homozygous mutation of MVK (encoding mevalonate kinase) that results in the substitution G1129A or compound mutations of MVK that result in the substitutions G632A and G1129A; the mechanism by which these substitutions cause inflammation remains unknown. Patients with PFAPA had no molecular diagnosis, except for one patient reported to have a heterozygous mutation of MEFV, which encodes pyrin (also known as marenostrin), a negative regulator of the inflammasome 54 .
Bacteria. M. catarrhalis (BAA-1425), H. influenzae type a (9006) and H. influenzae type b (9795) were cultured according to the manufacturer's instructions (American Type Culture Collection).
Cultures and reagents. Cells were cultured in complete RPMI medium supplemented with 10% (vol/vol) BSA. Purified B cells were incubated with CD40L (500 ng/ml; Amgen), BAFF (500 ng/ml; Alexis), APRIL MegaLigand (500 ng/ml; Alexis), IL-2 (100 ng/ml; Peprotech), IL-10 (50 ng/ml; Peprotech), IL-15 (50 ng/ml; Sigma) and IL-21 (100 ng/ml; R&D Systems). Cultures involving HIGM2 specimens included peripheral blood mononuclear cells instead of purified B cells because of the scarce amount of blood available. In these cultures, B cell activation was optimized with goat F(ab¢) 2 polyclonal anti-human IgM (5 mg/ml; H15000; Caltag). Purified basophils with Fc receptors already blocked during the purification step were incubated for 4 h with or without IL-3 (30 ng/ml; Peprotech). These basophils were stimulated with 5 ml microbeads coated with anti-mouse IgG (Miltenyi Biotec) mixed with one of the following antibodies: control IgG2a mAb with irrelevant binding activity (25 mg/ml; sc-3878; Santa Cruz Biotechnology), mouse IgG2a mAb to IgD (25 mg/ml; IA6-2; BD Biosciences) or mouse IgG2a mAb to IgE (2 mg/ml; G7-18; BD Biosciences). Basophils stimulated with equal amounts of microbeads only were included as an additional control. Basophil-B cell cocultures were set up by incubation of IgD + IgM + B cells for 1 h with basophils activated as described above (1:1 ratio). In these cocultures, basophils were washed extensively for elimination of excess mAb to IgD or IgE before the addition of B cells.
Flow cytometry. Cells were incubated with an Fc-blocking reagent (Miltenyi Biotec) or saturating concentrations of purified human IgG and were stained at 4 1C with the appropriate combinations of polyclonal and monoclonal antibodies to various surface antigens (Supplementary Table 1 ); 7-AAD was routinely used for the exclusion of dead cells from the analysis. All gates and quadrants were drawn to result in 1% or less of total positive cells in the sample stained with control antibodies. Events were acquired on a FACSCalibur or LSR II (BD Biosciences) and were analyzed by FlowJo (Tree Star). Tonsillar IgD + IgM À plasmablasts were identified in an electronic gate containing CD19 + mononuclear cells.
ELISA and cytometric bead array. IgD (Bethyl Laboratories), histamine (Neogen), and IL-1b, IL-4, IL-13, APRIL and TNF (Bender Medsystems) were measured by ELISA as recommended by the manufacturer. IL-8 and CXCL10 were measured by Human Th1/Th2 Cytometric Bead array (BD Biosciences). IgM, IgG, IgA and BAFF were detected by standard ELISA as described 16 ; IgE was measured by ELISA with mAb to human IgE (G7-18; BD Biosciences) as the capture antibody and biotinylated mAb to human IgE (G7-26; BD Biosciences) as the detection antibody. LL-37 was measured by ELISA with mouse mAb to LL-37 (3D11; Hycult Biotechnology) as the capture antibody and rabbit polyclonal anti-LL-37 (PA-AM5-002-1; PANATecs) as the detection antibody, followed by polyclonal anti-rabbit IgG conjugated to horseradish peroxidase (sc-2004; Santa Cruz Biotechnology). Human LL-37 peptide (PANATec) was used to generate a standard curve. Supernatants from basophil-containing cultures were centrifuged twice for 20 min at 18,000g and were adsorbed to mouse IgG before use in ELISA.
Genomic PCR, Southern blot analysis, cloning and sequencing. Active CSR from IgM to IgD was determined by PCR amplification of extrachromosomal s d -S m reciprocal DNA recombination products instead of ligated chromosomal S m -s d DNA products, which could be 'inflated' by the proliferation of the classswitched B cells. Genomic DNA was extracted with a QIAamp DNA Mini kit. The s d -S m switch circles were amplified from genomic DNA with elongase (Invitrogen) and a s d sense primer (5¢-TCATCATTGCCCAGATGCTAGGGCT-3¢) coupled with an S m antisense primer (5¢-TGAGTGCCCTCACT ACTTGCGTCCCG-3¢) in the following conditions: initial denaturation for 30 s at 94 1C, followed by 35 cycles of denaturation for 30 s at 94 1C, annealing for 30 s at 62 1C and extension for 7 min at 68 1C, and a final extension for 15 min at 68 1C. Products were resolved by electrophoresis through a 1% agarose gel, were transferred overnight onto nylon membranes and were hybridized with 32 P-labeled probes specific to the 3¢ portion of S m and the 5¢ portion of s d . For further verification of the specificity of PCR-amplified products, a second PCR was done in the same conditions with the s d sense primer 5¢-TCATCATTGCCCAGATGCTAGGGCT-3¢ coupled with the nested S m antisense primer 5¢-CAGACTGTCATGGCTATCAGGGGTGGCGGGG-3¢. PCR products longer than 1.5 kilobases were purified, ligated into pCR2.1 TOPO vectors and transformed into Escherichia coli with a TOPO TA cloning kit (Invitrogen). Plasmids in selected colonies were purified and sequenced. Sequences were aligned with human genomic DNA sequences for the identification of regions spanning both s d and S m .
RT-PCR. Active germline C d gene transcription and post-switch juxtaposition of chromosomal I m and C d exons were evaluated through the analysis of chimeric I m -C d transcripts in pre-switched and post-switched B cells, respectively. Total RNA was extracted with a QIAamp DNA Mini kit and RNeasy Mini kit (Qiagen) and cDNA was synthesized as described 16 . I m -C d transcripts were amplified from cDNA with Taq polymerase plus an I m sense primer (5¢-GTGATTAAGGAGAAA CACTTTGAT-3¢) and a C d antisense primer (5¢-CTGGCCAGCGGAAG ATCTCCTTCTT-3¢) in the following conditions: initial denaturation for 5 min at 94 1C, followed by 25 cycles of denaturation for 1 min at 94 1C, annealing for 1 min at 60 1C and extension for 1 min at 72 1C, and a final extension for 7 min at 72 1C. Bands were detected as described above with 32 P-labeled probes specific for I m and C d exons. RT-PCR products were cloned and sequenced for the identification of regions spanning both I m and C d .
Quantitative RT-PCR. Total RNA was extracted from basophils with TRIzol (Invitrogen); cDNA synthesis and quantitative RT-PCR were done with various primer pairs (Supplementary Table 2 ) as described 18 .
Calcium flux assay. Basophils (2.5 Â 10 6 ) were resuspended in 1 ml phosphate buffer solution, pH 7.4, containing 0.5% (vol/vol) BSA and 2 mM EDTA. Cells were loaded for 30 min at 37 1C with 5 mM Fura-3, acetoxymethyl ester form (Sigma). Excess Fura-3 was removed by washing of cells twice in phosphate buffer solution, then cells were stimulated. Intracellular Ca 2+ dynamics were monitored after the addition of stimulants in a plate reader with a 336-nm laser and a 495-nm filter. Readings were recorded every 40 s.
IgD binding assay. Polyclonal IgD purified from the plasma of healthy people (16-16-040704) or monoclonal IgD purified from the plasma of patients with multiple myeloma (16-16-090704 ; both from Athens Research & Technology) were incubated at various concentrations for 20 min at 4 1C with various cell types (1 Â 10 5 ). Binding assays were done with a concentration of IgD within or below the physiological range of serum IgD concentrations (15-300 mg/ml). Cells were then washed, stained with fluorescein-conjugated F(ab¢) 2 polyclonal anti-IgD (2032-02; Southern Biotech), washed again and analyzed by flow cytometry. This F(ab¢) 2 antibody had no cross-reactivity to other immunoglobulin classes (Supplementary Fig. 6 ) and could not bind to Fc receptors because of the lack of its Fc portion. Cells stained with this polyclonal anti-IgD in the absence of purified IgD were used as background control ( Supplementary Fig. 6 ). Alternatively, cells were stained with fluorescein-or phycocrythrinconjugated mouse mAb to IgD (IA6-2 (BD Biosciences) or IgD26 (Santa Cruz Biotechnology) or phycoerythrin).
Competitive IgD binding assays. Monoclonal IgD purified from the plasma of a patient with multiple myeloma was labeled with Alexa Fluor 488 with a Microscale Protein Labeling kit (Molecular Probes) and was dialyzed overnight in phosphate buffer solution, pH 7.4, for the removal of excess fluorochrome. Freshly isolated peripheral blood basophils were stripped of bound endogenous IgD by incubation for 3 min in an acidic sodium citrate buffer (40 mM sodium citrate and 140 mM NaCl, pH 3.0). Then, cells were quickly spun down for the removal of the acidic buffer and PBS was added to the cells for pH neutralization. Basophils stripped of endogenous bound IgD were incubated with unlabeled monoclonal IgD (0, 100 or 500 mg/ml), followed by Alexa Fluor 488-labeled monoclonal IgD (40 mg/ml). After incubation, cells were washed and analyzed by flow cytometry; 7-AAD was used for the exclusion of dead cells.
Statistical analysis. Statistical significance was assessed by a one-tailed unpaired Student's t-test.
